q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

March 2016 Summary of the new Medications added to Medicare Part D Plan Formularies (Drug Lists) Part 2: M-Z

Category: Monthly Formulary Changes
Published: Apr, 09 2016 01:04:35
< Previous
Next >
The March, 2016 Medicare Part D plan formulary data (or drug lists) includes the addition of 270 new National Drug Codes (NDC) to the Medicare Part D program.  These NDCs represent 158 different drugs, many with multiple strengths. There were so many new NDCs new to the March dataset, that we need to split this article into Part 1: (A-L) and Part 2: (M-Z) to coverage all of the new medications.

In addition to the generics discussed in Part 1: A-L, Memantine, the generic for Namenda; Molindone, the generic for Moban; Paliperidone, the generic for Invega; Penoxybenzamine, the generic for Dibenzyline; Pimozide, the generic for Orap; Repaglinide-Metformin, the generic for PrandiMet; Telmisartan-HCTZ, the generic for Micardis HCT; and Tetrabenazine, the generic for Xenazine were added to many 2016 Medicare Part D formularies.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 8
New Delivery Form and Strength 12
New Drug 59
New Drug and Delivery Form
 5
New Drug and Strength 78
New Drug, Delivery Form and Strength 4
New Manufacturer 7
New Manufacturer and Delivery Form 4
New Manufacturer and Strength 41
New Manufacturer, Strength and Delivery Form
 5
New Strength 47
Total New NDCs 270

Part 2 (M through Z): The following chart details the remaining 145 new manufacturer / drug / strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the March 2016 updates. You can click on the Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area. A chart of the first 125 NDCs can be found in Part 1: A-L.

NDC Drug Name Notes
42806001201 MECLIZINE 12.5 MG TABLET New Drug and Strength
42806001401 MECLIZINE 25 MG TABLET New Drug and Strength
49884023069 MEGESTROL 625 MG/5 ML SUSP New Drug
00591390087 MEMANTINE 5-10 MG TITRATION PK [Namenda Titration] New Drug and Strength
00527194313 MEMANTINE HCL 2 MG/ML SOLUTION [Namenda] New Drug and Strength
55111059660 MEMANTINE HCL 5 MG TABLET [Namenda] New Drug and Strength
00591387544 MEMANTINE HCL 10 MG TABLET [Namenda] New Drug and Strength
62175015337 METHYLPHENIDATE CD 30 MG CAP New Manufacturer and Strength
00781236401 METHYLPHENIDATE ER 40 MG CAP New Manufacturer and Strength
00115140801 METHYLTESTOSTERONE 10 MG CAP New Drug
43386058030 METOCLOPRAMIDE HCL ODT 10 MG New Strength
54766014923 MIACALCIN 400 UNIT/2 ML VIAL New Manufacturer and Strength
00004040509 MIRCERA 200 MCG/0.3 ML SYRINGE New Strength
59467031810 MITIGARE 0.6 MG CAPSULE New Drug
64720022810 MOLINDONE HCL 5 MG TABLET [Moban] New Drug and Strength
64720022910 MOLINDONE HCL 10 MG TABLET [Moban] New Drug and Strength
64720023010 MOLINDONE HCL 25 MG TABLET [Moban] New Drug and Strength
63323085074 MOXIFLOXACIN 400 MG/250 ML BAG [Avelox] New Manufacturer and Delivery Form
61748030311 MYORISAN 30 MG CAPSULE New Strength
00456121430 NAMZARIC 14 MG-10 MG CAPSULE New Drug and Strength
00456122830 NAMZARIC 28 MG-10 MG CAPSULE New Drug and Strength
52427027375 NAPRELAN CR 500 MG TABLET New Strength
52427027430 NAPRELAN CR 750 MG TABLET New Strength
00093100505 NAPROXEN DR 375 MG TABLET New Strength
00093100605 NAPROXEN DR 500 MG TABLET New Strength
47781015301 NAPROXEN SODIUM CR 375 MG TABLET New Strength
69547035302 NARCAN 4 MG NASAL SPRAY New Drug
00378695077 NEVIRAPINE ER 100 MG TABLET New Manufacturer and Strength
63020007801 NINLARO 2.3 MG CAPSULE New Drug and Strength
63020007901 NINLARO 3 MG CAPSULE New Drug and Strength
63020008001 NINLARO 4 MG CAPSULE New Drug and Strength
00591368401 NITROFURANTOIN MCR 25 MG CAP New Manufacturer
00591365801 NITROFURANTOIN MONO-MCR 100 MG New Manufacturer
00169770321 NORDITROPIN FLEXPRO 30 MG/3 ML New Strength
00173088101 NUCALA 100 MG VIAL New Drug
68982084001 OCTAGAM 5% VIAL New Strength
00078064515 ODOMZO 200 MG CAPSULE New Drug
61314001205 OFLOXACIN 0.3% EYE DROPS New Delivery Form and Strength
60505057501 OLOPATADINE HCL 0.1% EYE DROPS New Delivery Form and Strength
89141025014 ORAVIG 50 MG BUCCAL TABLET New Drug
65293001503 ORBACTIV 400 MG VIAL New Drug
51167080901 ORKAMBI 200 MG-125 MG TABLET New Drug
54436007504 OTREXUP 7.5 MG/0.4 ML AUTO-INJ New Strength
00378397893 PALIPERIDONE ER 1.5 MG TABLET [INVEGA] New Drug and Strength
00378397993 PALIPERIDONE ER 3 MG TABLET [INVEGA] New Drug and Strength
00378398093 PALIPERIDONE ER 6 MG TABLET [INVEGA] New Drug and Strength
00378398193 PALIPERIDONE ER 9 MG TABLET [INVEGA] New Drug and Strength
10337015380 PANDEL 0.1% CREAM New Drug
64380076921 PEG 3350-ELECTROLYTE SOLUTION New Manufacturer
00591298539 PHENADOZ 12.5 MG SUPPOSITORY New Drug
66993006602 PHENOXYBENZAMINE HCL 10 MG CAP [Dibenzyline] New Drug
49884034701 PIMOZIDE 1 MG TABLET [Orap] New Drug and Strength
49884034801 PIMOZIDE 2 MG TABLET [Orap] New Drug and Strength
00597010860 PRADAXA 110 MG CAPSULE New Strength
00024590101 PRALUENT 75 MG/ML PEN New Drug, Strength and Delivery Form
00024590301 PRALUENT 75 MG/ML SYRINGE New Drug, Strength and Delivery Form
00024590201 PRALUENT 150 MG/ML PEN New Drug, Strength and Delivery Form
00024590401 PRALUENT 150 MG/ML SYRINGE New Drug, Strength and Delivery Form
10370030511 PRAMIPEXOLE ER 2.25 MG TABLET New Manufacturer and Strength
10370025111 PRAMIPEXOLE ER 0.375 MG TABLET New Manufacturer and Strength
10370025211 PRAMIPEXOLE ER 0.75 MG TABLET New Manufacturer and Strength
10370025311 PRAMIPEXOLE ER 1.5 MG TABLET New Manufacturer and Strength
10370025411 PRAMIPEXOLE ER 3 MG TABLET New Manufacturer and Strength
55111061530 PRAMIPEXOLE ER 4.5 MG TABLET New Manufacturer and Strength
00591228560 PROPAFENONE HCL ER 225 MG CAP New Delivery Form
51672529203 PSORCON 0.05% CREAM New Drug
47781033530 PYRIDOSTIGMINE BR ER 180 MG TAB New Manufacturer and Strength
00185104710 QUINIDINE SULFATE 300 MG TAB New Strength
61364018101 RAPIVAB 200 MG/20 ML VIAL New Drug
75987005006 RAVICTI 1.1 GRAM/ML LIQUID New Drug
50484081015 REGRANEX 0.01% GEL New Drug
68180049001 REPAGLINIDE-METFORMIN 1-500 MG [PrandiMet] New Drug and Strength
68180049101 REPAGLINIDE-METFORMIN 2-500 MG [PrandiMet] New Drug and Strength
55513076001 REPATHA 140 MG/ML SURECLICK New Drug and Delivery Form
55513075001 REPATHA 140 MG/ML SYRINGE New Drug and Delivery Form
59148003513 REXULTI 0.25 MG TABLET New Drug and Strength
59148003613 REXULTI 0.5 MG TABLET New Drug and Strength
59148003713 REXULTI 1 MG TABLET New Drug and Strength
59148003813 REXULTI 2 MG TABLET New Drug and Strength
59148003913 REXULTI 3 MG TABLET New Drug and Strength
59148004013 REXULTI 4 MG TABLET New Drug and Strength
47335066868 RISEDRONATE SODIUM 35 MG TABLET [Actonel] New Manufacturer
47781040503 RIVASTIGMINE 13.3 MG/24HR PTCH New Manufacturer, Strength and Delivery Form
47781030403 RIVASTIGMINE 4.6 MG/24HR PATCH New Manufacturer, Strength and Delivery Form
47781030503 RIVASTIGMINE 9.5 MG/24HR PATCH New Manufacturer, Strength and Delivery Form
00078064681 SANDOSTATIN LAR DEPOT 10 MG KT New Delivery Form and Strength
00078064781 SANDOSTATIN LAR DEPOT 20 MG KT New Delivery Form and Strength
00078064881 SANDOSTATIN LAR DEPOT 30 MG KT New Delivery Form and Strength
16714036603 SETLAKIN 0.15 MG-0.03 MG TAB New Drug
00006171131 SINGULAIR 4 MG TABLET CHEW New Delivery Form
00006927531 SINGULAIR 5 MG TABLET CHEW New Delivery Form and Strength
00006911754 SINGULAIR 10 MG TABLET New Delivery Form and Strength
15054112003 SOMATULINE DEPOT 120 MG/0.5 ML New Strength
00597016061 SPIRIVA RESPIMAT 1.25 MCG INH New Strength
25682001601 STRENSIQ 40 MG/ML VIAL New Drug and Strength
25682001901 STRENSIQ 80 MG/0.8 ML VIAL New Drug and Strength
55111069305 SUMATRIPTAN 6 MG/0.5 ML INJECT New Manufacturer
00781317007 SUMATRIPTAN 4 MG/0.5 ML CART New Manufacturer and Strength
00781317307 SUMATRIPTAN 6 MG/0.5 ML REFILL New Manufacturer and Strength
63481036706 SUMAVEL DOSEPRO 6 MG/0.5 ML New Drug
00597016818 SYNJARDY 12.5-1,000 MG TABLET New Drug and Strength
00597018018 SYNJARDY 12.5-500 MG TABLET New Drug and Strength
00597017518 SYNJARDY 5-1,000 MG TABLET New Drug and Strength
00597015918 SYNJARDY 5-500 MG TABLET New Drug and Strength
00310134930 TAGRISSO 40 MG TABLET New Drug and Strength
00310135030 TAGRISSO 80 MG TABLET New Drug and Strength
00074308228 TECHNIVIE DOSE PACK New Drug
68180019309 TELMISARTAN-HCTZ 40-12.5 MG TB [Micardis HCT] New Drug and Strength
00603592716 TELMISARTAN-HCTZ 80-12.5 MG TB [Micardis HCT] New Drug and Strength
00603592816 TELMISARTAN-HCTZ 80-25 MG TAB [Micardis HCT] New Drug and Strength
68682042112 TETRABENAZINE 12.5 MG TABLET [XENAZINE] New Drug and Strength
68682042225 TETRABENAZINE 25 MG TABLET [XENAZINE] New Drug and Strength
50474030001 THEO-24 ER 300 MG CAPSULE New Strength
00143956501 THIOTEPA 15 MG VIAL New Drug
42023011925 TIGAN 100 MG/ML VIAL New Manufacturer and Strength
00187149825 TIMOPTIC 0.25% OCUDOSE DROP New Manufacturer and Strength
00187149605 TIMOPTIC 0.5% OCUDOSE DROP New Manufacturer and Strength
28105042140 TOLAK 4% CREAM New Drug
13811069030 TRAMADOL HCL ER 200 MG CAPSULE New Strength
00169266015 TRESIBA FLEXTOUCH 100 UNITS/ML New Drug and Strength
00169255013 TRESIBA FLEXTOUCH 200 UNITS/ML New Drug and Strength
68682080045 Tretinoin 0.05% gel New Manufacturer and Strength
65224085009 TREXIMET 85-500 MG TABLET New Drug
45963029530 TRIMIPRAMINE MALEATE 100 MG CP New Drug and Strength
45963029330 TRIMIPRAMINE MALEATE 25 MG CAP New Drug and Strength
45963029430 TRIMIPRAMINE MALEATE 50 MG CAP New Drug and Strength
00310080039 TUDORZA PRESSAIR 400 MCG INH New Drug and Strength
00310080060 TUDORZA PRESSAIR 400 MCG INH New Drug and Strength
59212020010 UROXATRAL 10 MG TABLET New Drug
42806050301 URSODIOL 300 MG CAPSULE New Manufacturer and Strength
69656010102 VARUBI 90 MG TABLET New Drug
53436008401 VELTASSA 8.4 GM POWDER PACKET New Drug and Strength
53436016830 VELTASSA 16.8 GM POWDER PACKET New Drug and Strength
53436025201 VELTASSA 25.2 GM POWDER PACKET New Drug and Strength
00093304301 VERAPAMIL ER 120 MG TABLET New Manufacturer
42211020523 VIVLODEX 5 MG CAPSULE New Drug and Strength
42211020623 VIVLODEX 10 MG CAPSULE New Drug and Strength
17478017324 XOPENEX 0.63 MG/3 ML SOLUTION New Manufacturer and Strength
17478017424 XOPENEX 1.25 MG/3 ML SOLUTION New Manufacturer and Strength
61314030401 ZARXIO 300 MCG/0.5 ML SYRINGE New Drug and Strength
61314031210 ZARXIO 480 MCG/0.8 ML SYRINGE New Drug and Strength
59212068010 ZONEGRAN 100 MG CAPSULE New Manufacturer and Strength
00173094555 ZOVIRAX 800 MG TABLET New Manufacturer and Strength
54123011430 ZUBSOLV 11.4-2.9 MG TABLET SL New Strength
54123092930 ZUBSOLV 2.9-0.71 MG TABLET SL New Strength


Related Article:
March 2016 summary of the new medications added to Medicare Part D plan formularies (drug lists) Part 1: A-L.

You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com


Ask a Pharmacist*
Have questions about your medication?

» Answers to Your Medication Questions, Free!
Available Monday - Friday
8am to 5pm MST
*A free service included with your no cost drug discount card.


© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.